QA: BRISTOL MYERS SQUIBB CO in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000014272_2022_BRISTOL_MYERS_SQUIBB_CO.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000014272, BRISTOL MYERS SQUIBB CO

  xvar xval
0 AssetsCurrent 33,262,000,000
1 IntangibleAssetsNetIncludingGoodwill 63,029,000,000
2 PropertyPlantAndEquipmentNet 6,049,000,000
3 remainder_Assets 6,974,000,000
4 LiabilitiesCurrent 21,868,000,000
5 LiabilitiesNoncurrent 46,939,000,000
6 remainder_Liabilities 4,501,000,000
7 CostOfGoodsAndServicesSold 9,940,000,000
8 SellingGeneralAndAdministrativeExpense 7,690,000,000
9 ResearchAndDevelopmentExpense 11,354,000,000
10 remainder_Expenses 10,387,000,000
11 remainder_Revenues 46,385,000,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 551,000,000
  yvar yval
0 Assets 109,314,000,000
1 Liabilities 73,308,000,000
2 Expenses 39,371,000,000
3 Revenues 46,385,000,000
4 StockholdersEquity 36,006,000,000
5 NetIncome 7,014,000,000
6 ComprehensiveNetIncome 7,289,500,000
7 BaseVar 134,464,500,000
8 EconomicCapitalRatio 0.758

Edgar->Model Mapping

Feature Distribution

Change over Time